MIDD conducts pre-clinical studies with Estrigenix’s lead for hot flashes and dementia

After a successful fund raising campaign, local startup company Estrigenix has engaged the MIDD to conduct pre-clinical characterization of their lead compounds. Estrigenix Therapeutics was formed in 2018 as a spin out from a collaboration research of three Milwaukee area… Read More

Function Therapeutics, Inc. moves to UWM

Milwaukee startup company Function Therapeutics moves to the Chemistry Department at UWM to conduct their R&D. The company is led by Dr. Chris Dockendorff (formerly Marquette Chemistry faculty), and is focused on the medicinal chemistry of a new class of… Read More

Two UWM startup companies received Phase II Bridge Funding from the UWM Research Foundation.

The University of Wisconsin Research Foundation’s Bridge Grant Program bolsters efforts to commercialize innovations developed at the UWM and foster development of startup companies that improve the Wisconsin economy. The program leverages a grant from the Wisconsin Economic Development Corporation… Read More